1. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001; 56:813–824.
2. Rabatin JT, Cowl CT. A guide to the diagnosis and treatment of occupational asthma. Mayo Clin Proc. 2001; 76:633–640.
3. Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, et al. Diagnosis and management of work-related asthma: American college of chest physicians consensus statement. Chest. 2008; 134:Suppl. 1S–41S.
4. Moscato G, Pala G, Barnig C, De Blay F, Del Giacco SR, Folletti I, et al. EAACI consensus statement for investigation of work-related asthma in non-specialized centres. Allergy. 2012; 67:491–501.
5. Bardana EJ Jr. 8. Occupational asthma and allergies. J Allergy Clin Immunol. 2003; 111:S530–S539.
7. Chapman MD. Allergen nomenclature. Clin Allergy Immunol. 2008; 21:47–58.
8. Kimber I, Dearman RJ. What makes a chemical a respiratory sensitizer? Curr Opin Allergy Clin Immunol. 2005; 5:119–124.
9. Baldo BA, Pham NH, Zhao Z. Chemistry of drug allergenicity. Curr Opin Allergy Clin Immunol. 2001; 1:327–335.
10. Larsen ST, Hansen R, Poulsen OM, Nielsen GD. Adjuvant effect of benzalkonium chloride on the allergen-specific IgE, IgG1 and IgG2a antibody formation in BALB/cJ mice. Basic Clin Pharmacol Toxicol. 2004; 95:94–96.
11. Kramps JA, van Toorenenbergen AW, Vooren PH, Dijkman JH. Occupational asthma due to inhalation of chloramine-T. II. Demonstration of specific IgE antibodies. Int Arch Allergy Appl Immunol. 1981; 64:428–438.
12. Zock JP, Kogevinas M, Sunyer J, Almar E, Muniozguren N, Payo F, et al. Asthma risk, cleaning activities and use of specific cleaning products among Spanish indoor cleaners. Scand J Work Environ Health. 2001; 27:76–81.
13. Vandenplas O, Suojalehto H, Aasen TB, Baur X, Burge PS, de Blay F, et al. Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement. Eur Respir J. 2014; 43:1573–1587.
14. Vandenplas O, Godet J, Hurdubaea L, Rifflart C, Suojalehto H, Wiszniewska M, et al. Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma? Allergy. 2019; 74:261–272.
15. Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, et al. Guidelines for the management of work-related asthma. Eur Respir J. 2012; 39:529–545.
16. Klusáčková P, Pelclová D, Jindriska Levedova D, Mareckova H, Brabec M. Occupational asthma after withdrawal from the occupational allergen exposure. Ind Health. 2006; 44:629–638.
18. Coates AL, Wanger J, Cockcroft DW, Culver BH. Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen. Diamant Z, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017; 49:1601526.
19. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161:309–329.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005; 26:319–338.
21. Vandenplas O, Suojalehto H, Cullinan P. Diagnosing occupational asthma. Clin Exp Allergy. 2017; 47:6–18.
22. Wiszniewska M, Nowakowska-Świrta E, Pałczyński C, Walusiak-Skorupa J. Diagnosing of bakers' respiratory allergy: is specific inhalation challenge test essential? Allergy Asthma Proc. 2011; 32:111–118.
23. Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014; 370:640–649.
24. Tan J, Bernstein JA. Occupational asthma: an overview. Curr Allergy Asthma Rep. 2014; 14:431.
25. Bernstein IL, Bernstein DI, Chan-Yeung M, Malo JL. Definition and classification of asthma in the workplace. In : Malo JL, Chan-Yeung M, Bernstein DI, editors. Asthma in the workplace. Boca Raton (FL): CRC Press;2013. p. 1–5.
26. Malo JL, Vandenplas O. Definitions and classification of work-related asthma. Immunol Allergy Clin North Am. 2011; 31:645–662.
27. Dufour MH, Lemière C, Prince P, Boulet LP. Comparative airway response to high- versus low-molecular weight agents in occupational asthma. Eur Respir J. 2009; 33:734–739.
28. Talini D, Novelli F, Bacci E, Dente FL, De Santis M, Di Franco A, et al. Comparison between airway responses to high versus low molecular weight compounds in occupational asthma. J Allergy (Cairo). 2011; 2011:781470.
29. Meca O, Cruz MJ, Sánchez-Ortiz M, González-Barcala FJ, Ojanguren I, Munoz X. Do low molecular weight agents cause more severe asthma than high molecular weight agents? PLoS One. 2016; 11:e0156141.
30. Pralong JA, Lemière C, Rochat T, L'Archevêque J, Labrecque M, Cartier A. Predictive value of nonspecific bronchial responsiveness in occupational asthma. J Allergy Clin Immunol. 2016; 137:412–416.
31. Lemiere C, NGuyen S, Sava F, D'Alpaos V, Huaux F, Vandenplas O. Occupational asthma phenotypes identified by increased fractional exhaled nitric oxide after exposure to causal agents. J Allergy Clin Immunol. 2014; 134:1063–1067.